Form 8-K - Current report:
SEC Accession No. 0001193125-19-322009
Filing Date
2019-12-23
Accepted
2019-12-23 09:06:40
Documents
14
Period of Report
2019-12-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d848792d8k.htm   iXBRL 8-K 28304
2 EX-99.1 d848792dex991.htm EX-99.1 12687
6 GRAPHIC g848792g74t64.jpg GRAPHIC 16846
  Complete submission text file 0001193125-19-322009.txt   192370

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fgen-20191223.xsd EX-101.SCH 3071
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20191223_lab.xml EX-101.LAB 18140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20191223_pre.xml EX-101.PRE 11409
9 EXTRACTED XBRL INSTANCE DOCUMENT d848792d8k_htm.xml XML 3395
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191303571
SIC: 2834 Pharmaceutical Preparations